Ultragenyx shares are trading lower after the company announced a proposed public offering of common stock.
Portfolio Pulse from Benzinga Newsdesk
Ultragenyx Pharmaceutical Inc. has announced a proposed public offering of common stock, causing its shares to trade lower.
October 18, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ultragenyx's announcement of a proposed public offering of common stock has led to a decrease in its share price.
Public offerings often lead to a decrease in share price due to dilution of shares. As Ultragenyx has announced a proposed public offering, it is expected that its share price will decrease in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100